EchoNext
Save to shortlistLast reviewed Nov 11, 2026 against the sources listed on this page · How we review
At a glance
EchoNext is an AI tool that analyzes standard 12-lead ECGs to flag hidden structural heart disease, including left- and right-sided heart failure, valve disease, severe hypertrophy consistent with…
- FDA:
- 510(k) K260332
- Epic:
- Not on record
- Named users:
- 2 reported by the maker
- Published study:
- Yes, linked below
Description
EchoNext is an AI tool that analyzes standard 12-lead ECGs to flag hidden structural heart disease, including left- and right-sided heart failure, valve disease, severe hypertrophy consistent with infiltrative cardiomyopathy and pulmonary hypertension, so patients can be referred for an echocardiogram. It was developed at NewYork-Presbyterian and Columbia and is commercialized by Pathway Labs; clinicians can access it through OpenEvidence. FDA 510(k) K260332, cleared June 8, 2026.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Is EchoNext FDA cleared?
- The public FDA database has one record that our team matched to EchoNext. The most recent is 510(k) K260332 (EchoNext), decided Jun 2026. Check that the cleared use matches how you plan to use it.FDA record K260332
- Is there published research on EchoNext?
- Yes, this listing links a published study. Check whether the patients and setting in the study look like yours.Some authors of this study work for or have financial ties to the maker.Read the study
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Not assessed
- Study authors
- Include people who work for or have financial ties to the maker
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
2 organizationsOrganizations named in public announcements or by the developer. Inclusion is not an endorsement.
Reported by the developer
Last checked Oct 31, 2026. Spot an error? Let us know through the discussion below.
Get weekly updates for Cardiology
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
Website Research PaperSome authors of this study work for or have financial ties to the maker.
FDA database records
- K260332 · 510(k) · Jun 2026EchoNext
Matched by our team from the public FDA database; checked Nov 10, 2026.
History (2)Show
Dated events on this listing's public record, newest first.
- Sep 13, 2026
Added to CIFoundry
- Jun 8, 2026
FDA 510(k) K260332 decision datesource
Developer
Pathway Labs (Pathwai, Inc.)
Pathway Labs / Columbia University Irving Medical Center / NewYork-Presbyterian
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →